Featuring market attractiveness scoring, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, deeper supply chain intelligence, emerging startup tracking, and granular product-level insights, The Business Research Company’s 2026 market reports are built to deliver research that is both more actionable and more strategically valuable.
#Gastric Cancer Diagnostic Market Growth Analysis: How Will Revenue Trend Over The Forecast Period?#_x000D_
The gastric cancer diagnostic market has shown significant growth in recent times. It is forecast to increase from $2.78 billion in 2025 to $2.98 billion in 2026, achieving a compound annual growth rate (CAGR) of 7.2%. This historical expansion can be attributed to several factors, including the limited availability of fluorescent probes, a reliance on traditional single-color FISH methods, growing genetic research initiatives, an increase in hospital and laboratory infrastructure, and the adoption of basic cytogenetic diagnostics._x000D_
_x000D_
Significant expansion is anticipated for the gastric cancer diagnostic market in the upcoming years. Projections indicate its value will reach $3.87 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 6.8%. This growth during the forecast period is propelled by factors such as the creation of multiplex and high-throughput probes, the increasing need for precision medicine, broader genetic and pharmaceutical research, improvements in imaging and quantification technologies, and stricter regulatory compliance and quality standards. Key trends expected over the forecast period encompass a greater uptake of multiplex and high-throughput FISH probes, an increase in genetic and molecular diagnostic applications, expanded utilization in clinical and pharmaceutical research, the incorporation of advanced imaging and analysis technologies, and a sharpened emphasis on probe accuracy and sensitivity._x000D_
_x000D_
#Get A Free Sample Report With In-Depth Market Insights:#_x000D_
_x000D_
#Gastric Cancer Diagnostic Market Growth Factors Behind Sustained Expansion#_x000D_
The increasing occurrence of gastric cancer is anticipated to drive the expansion of the gastric cancer diagnostic market in the future. Gastric cancer is defined as a malignant tumor located in the stomach lining, characterized by the uncontrolled proliferation of cells, which creates a mass capable of invading adjacent tissues and metastasizing throughout the body. This growing incidence of gastric cancer stems from unhealthy dietary practices, since a significant intake of salted, smoked, and processed foods elevates the risk of stomach lining damage and subsequent cancer development. Gastric cancer diagnostics assist in diagnosing gastric cancer by allowing for the early identification of malignant lesions, which is crucial for prompt treatment and better patient recovery. These diagnostics improve clinical effectiveness through the provision of accurate and quick results, thereby facilitating enhanced disease management. For example, data from May 2024, published by the American Cancer Society, a US-based nonprofit organization, indicated that new stomach cancer cases totaled 26,890 in 2024, marking an increase from 26,500 cases reported in 2023. Consequently, the escalating incidence of gastric cancer is a key factor propelling the growth of the gastric cancer diagnostic market._x000D_
_x000D_
#Gastric Cancer Diagnostic Market Segment Breakdown: Which Categories Lead On Revenue?#_x000D_
The gastric cancer diagnostic market covered in this report is segmented – _x000D_
_x000D_
1) By Diagnostic Type: Endoscopy, Imaging, Biopsy, Laboratory Tests, Biomarker-Based Testing_x000D_
2) By Product: Reagents And Consumables, Instruments_x000D_
3) By Technology: Molecular Diagnostics, Immunoassays, Next-Generation Sequencing, Other Technologies_x000D_
4) By Application: Early Diagnosis, Screening, Monitoring_x000D_
5) By End User: Hospitals, Clinics, Diagnostic Laboratories, Other End Users_x000D_
_x000D_
Subsegments:_x000D_
1) By Endoscopy: Conventional Endoscopy, Chromoendoscopy, Narrow Band Imaging, Confocal Laser Endomicroscopy, Capsule Endoscopy_x000D_
2) By Imaging: Computed Tomography, Magnetic Resonance Imaging, Positron Emission Tomography, Ultrasound_x000D_
3) By Biopsy: Forceps Biopsy, Needle Biopsy, Endoscopic Ultrasound-Guided Biopsy, Laparoscopic Biopsy_x000D_
4) By Laboratory Tests: Blood Tests, Stool Tests, Urea Breath Test, Serology_x000D_
5) By Biomarker-Based Testing: Genetic Testing, Protein Biomarker Testing, Circulating Tumor DNA Testing, Microribonucleic Acid Testing_x000D_
_x000D_
#Gastric Cancer Diagnostic Market Industry Trends Fueling Future Revenue Growth#_x000D_
Companies operating within the gastric cancer diagnostic market are concentrating on the creation of cutting-edge diagnostic instruments, such as artificial intelligence-based endoscopic diagnostic support devices, to enhance both early detection capabilities and diagnostic accuracy. Artificial intelligence-based endoscopic diagnostic support devices are AI-driven tools that assist in identifying and evaluating gastrointestinal abnormalities during an endoscopy. As an example, in March 2024, AI Medical Service Inc., a Japanese medical technology firm, launched GastroAI-model G, an AI-powered system designed to support endoscopic diagnosis. This system helps gastroenterologists during endoscopic procedures by analyzing video images in real time to locate potential cancerous lesions. It leverages deep learning to detect suspicious areas indicative of early gastric cancer, which may require a biopsy or further examination. When these lesions are identified, the system instantly alerts the physician by highlighting the area with a rectangle on the endoscopic screen, thereby improving diagnostic accuracy and enabling earlier cancer detection._x000D_
_x000D_
#Gastric Cancer Diagnostic Market Competitive Overview And Top Companies#_x000D_
Major companies operating in the gastric cancer diagnostic market are F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Abbott Laboratories, Becton Dickinson and Company, Quest Diagnostics Incorporated, Agilent Technologies Inc., Illumina Inc., bioMérieux SA, Qiagen N.V., DiaSorin S.p.A, Natera Inc., Myriad Genetics Inc., Fulgent Genetics Inc., Foundation Medicine Inc., Invitae Corporation, NeoGenomics Laboratories Inc., Fujirebio Inc., MiRXES Pte Ltd., BIOCEPT Inc., Pillar Biosciences Inc. _x000D_
_x000D_
#View The Full Gastric Cancer Diagnostic Market Report:#_x000D_
_x000D_
#Gastric Cancer Diagnostic Market Top Region: Where Does Most Revenue Come From?#_x000D_
North America was the largest region in the gastric cancer diagnostic market in 2025. Asia Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the gastric cancer diagnostic market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa._x000D_
_x000D_
#Reach Out To Our Team:#_x000D_
_x000D_
The Business Research Company: https://www.thebusinessresearchcompany.com/_x000D_
Americas: +1 310-496-7795_x000D_
Asia: +44 7882 955267 & +91 8897263534_x000D_
Europe: +44 7882 955267_x000D_
Email us at: marketing@tbrc.info_x000D_
_x000D_
#Follow us on:#_x000D_
_x000D_
LinkedIn: https://in.linkedin.com/company/the-business-research-company_x000D_
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ_x000D_
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Wasay has over a decade of experience in market research, data modelling, and analytics, with prior experience at GlobalData and Decision Tree Consulting Services. At The Business Research Company , he leads research operations across syndicated studies, customized consulting engagements, and the Global Market Model platform. His professional experience includes supporting organizations such as Boston Consulting Group, KPMG, and Ernst & Young. Wasay holds a degree in Electronics and Communications Engineering, postgraduate management qualifications from International Management Institute Belgium and Indian School of Business and Entrepreneurship, and completed the Integrated Program in Business Analytics from Indian Institute of Management Indore.
